Researchers at Karolinska Institutet in Sweden and the University of North Carolina in the USA have mapped out the cell types behind various brain disorders. The findings are published in Nature Genetics and offer a roadmap for the development of new therapies to target neurological and psychiatric disorders. One interesting finding was that cells from the gut’s nervous system are involved in Parkinson’s disease, indicating that the disease may start there.

The nervous system is composed of hundreds of different cell types with very different functions...

Laser opens up a new world of applications using optical control of physical objects. Researchers have demonstrated the world’s first metasurface laser that produces “super-chiral light”: light with ultra-high angular momentum. The light from this laser can be used as a type of “optical spanner” to or for encoding information in optical communications.

“Because light can carry angular momentum, it means that this can be transferred to matter. The more angular momentum light carries, the more it can transfer. So you can think of light as an ‘optical spanner’,” Professor Andrew Forbes from the School of Physics at the University of the Witwatersrand (Wits) in Johannesburg, South Africa, who led the research...

The NASA/ESA Hubble Space Telescope has provided astronomers with the sharpest view yet of the breakup of Comet C/2019 Y4 (ATLAS). The telescope resolved roughly 30 fragments of the fragile comet on 20 April and 25 pieces on 23 April.

The comet was first discovered in December 2019 by the ATLAS (Asteroid Terrestrial-impact Last Alert System) robotic astronomical survey system in Hawaiʻi, USA...

Immunotherapy combo that encourages immune cells to consume tumors could lead to long-term remission for glioblastoma. A combination of immunotherapy agents that encourages some immune cells to eat cancer cells and alert others to attack tumors put mice with a deadly type of brain cancer called glioblastoma into long-term remission, a new study led by UT Southwestern scientists suggests. The finding, published online March 20, 2020, in Nature Communications, could lead to new therapies that may significantly extend survival for human glioblastoma patients, which stands at an average of 15 months after diagnosis even with current state-of-the-art therapies.

The immune system has two branches: innate immunity, an evolutionarily older system that continually scans the b...